Effect of nitric oxide on rat adrenal zona fasciculata steroidogenesis

Journal of Endocrinology

Volumn 158, Issue 2, 1998, Pages 197-203

  Cymeryng, C B ^a   Dada, L A ^a   Podesta E J ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; NITRIC OXIDE; PREGNENOLONE; PROGESTERONE;

ADRENAL CORTEX FUNCTION; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL METABOLISM; HORMONAL REGULATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; RAT; ZONA FASCICULATA;

EID: 0031858672     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1580197     Document Type: Article

References (30)

1. G-nitro-L-arginine and comparisons to alcohol. Life Sciences 50 35-40.
2. Bredt DS & Snyder SH 1989 Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proceedings of the National Academy of Sciences of the USA 86 9030-9033.
3. Bredt DS & Snyder SH 1992 Nitric oxide, a novel neuronal messenger. Neuron 8 3-11.
4. Bredt DS & Snyder SH 1994 Nitric oxide: a physiologic messenger molecule. Annual Review of Biochemistry 63 175-195.
5. Cameron LA & Hinson JP 1993 The role of nitric oxide derived from L-arginine in the control of steroidogenesis, and perfusion medium flow rate in the isolated perfused rat adrenal gland. Journal of Endocrinology 139 415-423.
6. Ceccatelli S, Hultin AL, Zhang X, Gustafsson L, Villar M & Hökfelt T 1993 Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in the regulation of luteinizing hormone secretion. Proceedings of the National Academy of Sciences of the USA 90 11292-11296.
7. Dave S, Farrance DP & Whitehead SA 1997 Evidence that nitric oxide inhibits steroidogenesis in cultured rat granulosa cells. Clinical Science 92 277-284.
8. Del Punta K, Charreau EH & Pignataro OP 1996 Nitric oxide inhibits Leydig cell steroidogenesis. Endocrinology 137 5337-5343.
9. Duvilansky BH, Zambruno C, Seilicovich A, Pisera D, Lasaga M, Díaz MC, Belova N, Rettori V & McCann SM 1995 Role of nitric oxide in control of prolactin release by the adenohypophysis. Proceedings of the National Academy of Sciences of the USA 92 170-174.
10. Farese R 1970 Inhibition of cholesterol side chain cleavage by cyanoketone. Steroids 15 245-250.
11. Giordano M, Vermeulen M, Trevani A, Dran G, Andonegui G & Geffner JR 1996 Nitric oxide synthase inhibitors enhance plasma levels of corticosterone and ACTH. Acta Physiologica Scandinavica 157 259-264.
12. Ientile R, Picciurro V, Pedale S, Nucci C, Malecka B, Nistico G & Macaione S 1996 Nitric oxide enhances amino acid release from immature chick embryo retina. Neuroscience Letters 219 79-82.
13. Ignarro LJ 1989 Endothelium-demed nitric oxide: actions and properties. FASEB Journal 3 31-36.
14. Lincoln TM &: Cornwell TL 1993 Intracellular cyclic GMP receptor proteins. FASEB Journal 7 328-338.
15. Moncada S, Palmer RMJ & Higgs EA 1991 Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacological Reviews 43 109-142.
16. Nakayama T, Izumi Y, Soma M & Kanmatsuse K 1996 A nitric oxide synthesis inhibitor prevents the ACTH-stimulated production of aldosterone in rat adrenal gland. Endocrine Journal 43 157-162.
17. Natarajan R, Lanting L, Bai W, Bravo EL & Nadler J 1997 The role of nitric oxide in the regulation of aldosterone synthesis by adrenal glomerulosa cells. Journal of Steroid Biochemistry and Molecular Biology 61 47-53.
18. Nathan C 1992 Nitric oxide as a secretory product of mammalian cells. FASEB Journal 6 3051-3064.
19. Neher R & Milani A 1978 Steroidogenesis in isolated adrenal cells: excitation by calcium. Molecular and Cellular Endocrinology 9 243-253.
20. Neher R, Milani A, Solano A & Podestá E 1982 Compartmentalization of corticotropin-dependent steroidogenic factors in adrenal cortex: evidence for a post-translational cascade in stimulation ot cholesterol side chain split. Proceedings of the National Academy of Sciences of the USA 79 1727-1731.
21. Palacios M, Knowles RG, Palmer RMJ & Moncada S 1989 Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochemical and Biophysical Research Communications 165 802-809.
22. Rettori V, Belova N, Dees WL, Nyberg CL, Gimeno M & McCann SM 1993 Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Proceedings of the National Academy of Sciences of the USA 90 10130-10134.
23. Romero DG, Pecci A, Lantos CP & Cozza EN 1996 Endothelin-1-induced incorporation of cholesterol into rat adrenals. Steroids 61 317-322.
24. Schmidt HHHW 1992 NO, CO and OH: endogenous soluble guanylyl cyclase-activating factors. FEBS Letters 307 102-107.
25. Schmidt HHHW, Warner TD, Ishii K, Shenk H & Murad F 1992 Insulin secretion from pancreatic B cells caused by L-arginne-delivered nitrogen oxides. Science 255 721-723.
26. Snyder GD, Holmes RW, Bates JN & Van Voorhis BJ 1996 Nitric oxide inhibits aromatase activity: mechanisms of action. Journal of Steroid Biochemistry and Molecular Biology 58 63-69.
27. Snyder SH & Bredt DS 1991 Nitric oxide as a neuronal messenger. Trends in Pharmacological Sciences 12 125-128.
28. Van Voorhis BJ, Dunn MS, Snyder GD & Weiner CP 1994 Nitric oxide: an autocrine regulator of human granulosa-luteal cell steroidogenesis. Endocrinology 135 1799-1806.
29. Welch C, Watson ME, Poth M, Hong T & Francis GL 1995 Evidence to suggest nitric oxide is an interstitial regulator ot Leydig cell steroidogenesis. Metabolism 44 234-238.
30. Wink DA, Osawa Y, Darbybire JF, Jones CR, Eshenaur SC & Nims RW 1993 Inhibition of cytochromes P450 by nitric oxide and a nitric oxide releasing agent. Archives of Biochemistry and Biophysics 300 115-123.